MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-PY-03-0001549
Pregio Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.7 Cr
▲ 34% YoY
Net profit · FY 2024
₹77.06 Lakh
Net margin 1.8%
EBITDA · FY 2024
₹2.33 Cr
EBITDA margin 5.6%
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹12.32 Cr
Issued & subscribed
Open charges
₹12.2 Cr
Satisfied ₹8.4 Cr
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Pregio Pharma Private Limited
Data last updated:
Pregio Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24297TN2011PTC079939. Its GSTIN is 33AAGCP1812J1ZN (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.32 Cr. It is led by directors Muthuvelayudham Sivakumar (Managing Director) and Sasikumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1035 A New No 11 H – Block 24th Street Anna Nagar West Chennai 600040, Tamil Nadu, India – 600040.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.7 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹77.06 Lakh (net margin 1.8%) and EBITDA of ₹2.33 Cr (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 10% over five years.
The company is associated with 1 brand: Pregio Pharma. As per MCA filings, the company has open charges of ₹12.2 Cr and satisfied charges of ₹8.4 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Samrudh Pharmacare Private Limited with revenue of ₹41.88 Cr.
Pregio Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0001549). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pregiopharma.in.
Company details
CIN U24297TN2011PTC079939
Registration Number 079939
Incorporation Date 30 March 2011
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0001549
Recognitions & Rankings of Pregio Pharma
Contact details
Pregio Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is pregiopharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1035 A New No 11 H – Block 24th Street Anna Nagar West Chennai 600040, Tamil Nadu, India – 600040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pregio Pharma Private Limited, buy the company report.
Comprehensive company report
Pregio Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pregio Pharma operates one associated brand: Pregio Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing quality medicines including cardiac and anti-diabetics drugs in India. | pregiopharma.in |
Business activity
The main business activity of Pregio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pregio Pharma Private Limited, buy the company report.
Financials of Pregio Pharma Private Limited
FY 2024 filings availablePregio Pharma Private Limited reported revenue of ₹41.7 Cr (up 34% YoY) for FY 2024.
Revenue · FY 2024
₹41.7 Cr ▲ 34%
Net profit · FY 2024
₹77.06 Lakh margin 1.8%
EBITDA · FY 2024
₹2.33 Cr margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 26%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 28%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 34% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pregio Pharma Private Limited, buy the company report.
Board of directors of Pregio Pharma Private Limited
Pregio Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muthuvelayudham Sivakumar | Managing Director | 30 Mar 2011 | 15 Years 6 Months | Current |
| Sasikumar | Director | 28 Oct 2016 | 9 Years 11 Months | Current |
Peer comparison
Pregio Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India | |||
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | -13.0% | Hyderabad, Telangana, India | |||
| Elbrit Life Sciences Private Limited | ₹41.77 Cr (FY 2024) | 39.0% | Erode, Tamil Nadu, India | |||
| Crest Lifesciences Private Limited | ₹41.71 Cr (FY 2025) | 397.0% | Baddi, Himachal Pradesh, India | |||
| Pregio Pharma Private Limitedthis company | ₹41.7 Cr (FY 2024) | ₹77.06 Lakh | 1.8% | 34.0% | Chennai, Tamil Nadu, India | |
| Strava Healthcare Private Limited | ₹41.58 Cr (FY 2025) | 115.0% | Ahmedabad, Gujarat, India | |||
| J M Healthcare Private Limited | ₹41.39 Cr (FY 2024) | 29.0% | Chandigarh, India | |||
| Curium Pharma (India) Private Limited | ₹41.38 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Pregio Pharma Private Limited, buy the company report.
Shareholding
The shareholding of Pregio Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pregio Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.2 Cr
Satisfied charges
₹8.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2023 | 100825195 | Indian Overseas Bank | ₹8.03 Lakh | Open | |
| 28 Jul 2023 | 100765547 | Indian Overseas Bank | ₹12.12 Cr | Open | |
| 31 Dec 2019 | 100318226 | The South Indian Bank Limited | ₹4.42 Cr | Satisfied | |
| 30 May 2013 | 10429633 | Others | ₹3.98 Cr | Satisfied |
To see the full charge records of Pregio Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Pregio Pharma Private Limited has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019.
Total deals
5
Funding rounds
5
Disclosed funding
₹5.62 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹2.18 Cr | Investors: 4 individuals |
| Mar 2017 | Funding round | ₹1.48 Cr | Investors: 3 individuals |
| Mar 2016 | Funding round | ₹67.1 Lakh | Investors: 3 individuals |
| May 2012 | Funding round | ₹1.19 Cr | Investors: 4 individuals |
| Jan 2012 | Funding round | ₹10 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pregio Pharma Private Limited has 8 court cases on record: 4 filed by Pregio Pharma, 4 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
4
Filed against the company
4
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 2 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed against the company by Scope Ingredients Pvt Ltd | Disposed |
| District court, Mancherial, Telangana | Criminal complaint | Filed against the company by State of Telangana Represented Nu Drugs Inspector, Mancherial District | Pending |
| District court, Krishna, Andhra Pradesh | Criminal complaint | Filed against the company by Ap State Rep. by the Drugs Inspector, Gudivada Zone | Pending |
| District court, Krishna, Andhra Pradesh | Court case (PRC) | Filed against the company by The State of Andhra Pradesh Rep., by the Drugs Inspector, Gudivada Zone | Disposed |
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
To see the full case history of Pregio Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pregio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pregio Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCP1812J1ZN | Tamil Nadu | Active | 06 Jul 2021 |
| 34AAGCP1812J1ZL | Puducherry | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pregio Pharma Private Limited, buy the company report.
Recent activity
Pregio Pharma Private Limited has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Viswanathan Palaniappan ceased to be Company Secretary on 06 Jan 2025.
Charges
A charge with Indian Overseas Bank of Rs. 12.12 Cr registered on 28 Jul 2023 with Charge ID 100765547 was modified on 27 May 2025.
Ceased
Viswanathan Palaniappan ceased to be Company Secretary.
AGM
Pregio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Pregio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.08 Cr with Charge ID 100825195 was registered on 21 Nov 2023.
Charges
A charge registered on 31 Dec 2019 via Charge ID 100318226 with The South Indian Bank Limited was fully satisfied on 17 Aug 2023.
Charges
A charge with Indian Overseas Bank amounted to Rs. 12.12 Cr with Charge ID 100765547 was registered on 28 Jul 2023.
Ceased
Deivasigamani Shanmuga Sundaram ceased to be Additional Director.
Charges
A charge with The South Indian Bank Limited of Rs. 4.42 Cr registered on 31 Dec 2019 with Charge ID 100318226 was modified on 26 Sep 2022.
Ceased
Mohanrajulu Srinivasa Naidu ceased to be Additional Director.
Charges
A charge registered on 30 May 2013 via Charge ID 10429633 with Others was fully satisfied on 06 Jan 2020.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 4.42 Cr with Charge ID 100318226 was registered on 31 Dec 2019.
9 earlier events are in the company report.
Frequently asked questions
Pregio Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2011 (15+ years old) and is registered under CIN U24297TN2011PTC079939.
Pregio Pharma has 2 current directors:
- Muthuvelayudham Sivakumar - Managing Director
- Sasikumar - Director
The latest financial statements of Pregio Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pregio Pharma is 33AAGCP1812J1ZN, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAGCP1812J1ZL (Puducherry).
The CIN (Corporate Identification Number) of Pregio Pharma is U24297TN2011PTC079939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pregio Pharma has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Pregio Pharma was incorporated on 30 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
Pregio Pharma has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019.
The peers of Pregio Pharma by revenue are Samrudh Pharmacare Private Limited, Aap Pharma Technologies India Private Limited, Elbrit Life Sciences Private Limited, Crest Lifesciences Private Limited, Strava Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Viswanathan Palaniappan ceased to be Company Secretary on 06 Jan 2025. Deivasigamani Shanmuga Sundaram ceased to be Additional Director on 04 Nov 2022. Mohanrajulu Srinivasa Naidu ceased to be Additional Director on 11 Jun 2022. Pregio Pharma has 9 board changes on record in total.
Yes, Pregio Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0001549).